by John Conrad | Oct 8, 2024 | Member News
Astellas Pharma Inc. and AviadoBio Ltd. have announced an exclusive option and license agreement for AVB-101, a promising gene therapy currently in Phase 1/2 clinical trials. This collaboration marks a significant step forward in addressing the urgent need for...
by John Conrad | Sep 19, 2024 | NewsBrief
Syntax Bio has launched with $15 million in funding from notable investors, including Astellas Venture Management LLC and Illumina Ventures. The Chicago-based startup is pioneering a novel approach to cell therapy with its Cellgorithm platform. Syntax Bio’s...
by John Conrad | Apr 3, 2020 | COVID, iBIO News
Following the March 23rd launch of the iBIO COVID-19 PPE Response Fund, we are pleased to announce significant growth in the donation of funds and medical supplies from the life sciences community. Currently the fund has received more than $750,000 in cash...
by John Conrad | Aug 2, 2019 | EDUCATE
The 2019 STEMgirls Summer Camps were held June 3-7 at Southwest Illinois College in Red Bud, IL and June 17-21 at Cristo Rey St. Martin College Prep in Waukegan, IL. The camps were made possible through the generous support of Abbott, Astellas Pharma, Horizon...
by John Conrad | Jun 17, 2019 | EDUCATE, iBIO News
Today, the iBIO’s EDUCATE Center kicked off its fourth annual STEMgirls Summer Camp hosted at Cristo Rey St. Martin College Prep in Waukegan. This week-long learning experience provides 130young girls (grades 3-8) with opportunities to learn more about careers in...
